BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10445571)

  • 1. Amitriptyline absorption in a patient with short bowel syndrome.
    Robbins B; Reiss RA
    Am J Gastroenterol; 1999 Aug; 94(8):2302-4. PubMed ID: 10445571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing of antidepressants--the unknown art.
    Jerling M
    J Clin Psychopharmacol; 1995 Dec; 15(6):435-9. PubMed ID: 8748433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic antidepressant plasma levels after fluoxetine addition.
    Vandel S; Bertschy G; Bonin B; Nezelof S; François TH; Vandel B; Sechter D; Bizouard P
    Neuropsychobiology; 1992; 25(4):202-7. PubMed ID: 1454161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects.
    Sennef C; Timmer CJ; Sitsen JM
    Hum Psychopharmacol; 2003 Mar; 18(2):91-101. PubMed ID: 12590402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual case of prolonged tinnitus following low-dose amitriptyline.
    Mendis D; Johnston M
    J Psychopharmacol; 2008 Jul; 22(5):574-5. PubMed ID: 18308819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: adverse effects of taking tricyclic antidepressants and smoking marijuana.
    Mannion V
    Can Fam Physician; 1999 Nov; 45():2683-4. PubMed ID: 10587776
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut AY; Chevanne F; Le Corre P
    Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case 7: the addled nonagenarian.
    Shader RI; Oesterheld JR
    J Clin Psychopharmacol; 1995 Oct; 15(5):378. PubMed ID: 8830074
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of therapeutic drug monitoring of amitriptyline and genotyping on efficacy and safety of depression therapy].
    Ostapowicz A; Zejmo M; Wrześniewska J; Białecka M; Górnik W; Gawrońska-Szklarz B
    Psychiatr Pol; 2000; 34(4):595-605. PubMed ID: 11059259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered pharmacokinetics of tricyclic antidepressants in burns.
    Crompton DR; Pegg SP; Jellett LB; Middleton W
    Aust N Z J Psychiatry; 1991 Sep; 25(3):419-21. PubMed ID: 1958167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice.
    Pfuhlmann B; Gerlach M; Burger R; Gonska S; Unterecker S; Jabs B; Riederer P; Deckert J
    J Neural Transm Suppl; 2007; (72):287-96. PubMed ID: 17982905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients.
    Moreno-Fernández AM; Cordero MD; Garrido-Maraver J; Alcocer-Gómez E; Casas-Barquero N; Carmona-López MI; Sánchez-Alcázar JA; de Miguel M
    J Psychiatr Res; 2012 Mar; 46(3):341-5. PubMed ID: 22118833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of metabolic interaction: amitriptyline, fluoxetine, antitubercular agents].
    Bertschy G; Vandel S; Perault MC
    Therapie; 1994; 49(6):509-12. PubMed ID: 7878612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rampant dental caries in the treatment of depression.
    Bassuk E; Schoonover S
    J Clin Psychiatry; 1978 Feb; 39(2):163-5. PubMed ID: 580266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.